 CollPlant NASDAQ: CLGN, a regenerative medicine company, today announced financial results for the third quarter ended September 30, 2019 and provided an update on the Companys business developments. Certain metrics, including those expressed on an adjusted basis, are non-GAAP measures. See Use of Non-IFRS non-GAAP Measures below. 